Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
47 hedge funds and large institutions have $6.25M invested in Nymox Pharmaceutical Corp in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 18 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
2% more funds holding
Funds holding: 46 → 47 (+1)
0.75% less ownership
Funds ownership: 8.23% → 7.48% (-0.75%)
39% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 18
49% less capital invested
Capital invested by funds: $12.3M → $6.25M (-$6.04M)
59% less call options, than puts
Call options by funds: $123K | Put options by funds: $300K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$154K |
| 2 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$69.1K |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
+$48.9K |
| 4 |
JP Morgan Chase
New York
|
+$33.5K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$24.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$288K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
-$220K |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$72.6K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$57.4K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$55.2K |
NYMX Hedge Fund Activity: Q4 2018 in Review
47 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q4 2018, worth a combined $6.25M — down 49% from $12.3M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NYMX positions and 2 closed out — a net gain of 1 holder — while 11 added to existing stakes and 18 trimmed.
The largest buyer was Bank of America, adding an estimated $154K. The largest seller was Susquehanna International Group, cutting an estimated $288K.
- 47 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q4 2018, up from 46 in Q3 2018.
- Funds reported $6.25M of Nymox Pharmaceutical Corp stock for Q4 2018, down 49% quarter-over-quarter.
- 3 funds opened new Nymox Pharmaceutical Corp positions in Q4 2018 and 2 closed out, a net change of +1 holder.
- The largest Nymox Pharmaceutical Corp buyer in Q4 2018 was Bank of America, an estimated $154K added.
- The largest Nymox Pharmaceutical Corp seller in Q4 2018 was Susquehanna International Group, an estimated $288K sold.
Based on aggregated 13F filings for Q4 2018.